Canada's Michael Smith Genome Sciences Centre
The Genome Sciences Centre (GSC) is distinguished by its strong integration of research and clinical practice, fostering close collaboration between scientists and clinicians to enable real-time translational impact. Through the Personalized OncoGenomics (POG) program, the GSC applies whole genome and transcriptome sequencing to guide therapeutic decision-making for patients with advanced cancers. In addition to its research mandate, the GSC is accredited by the College of American Pathologists
Basic Information
- Category: organization
- Website: http://www.bcgsc.ca/
Documented Facts
- Email: info@bcgsc.ca (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore organization profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Canada's Michael Smith Genome Sciences Centre.
- Canonical profile: https://brandsource.ai/brands/canada-s-michael-smith-genome-sciences-centre
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/canada-s-michael-smith-genome-sciences-centre/json-ld
- Citation profile API: https://brandsource.ai/api/brands/canada-s-michael-smith-genome-sciences-centre/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
The Genome Sciences Centre (GSC) is distinguished by its strong integration of research and clinical practice, fostering close collaboration between scientists and clinicians to enable real-time translational impact. Through the Personalized OncoGenomics (POG) program, the GSC applies whole genome and transcriptome sequencing to guide therapeutic decision-making for patients with advanced cancers. In addition to its research mandate, the GSC is accredited by the College of American Pathologists
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.